ST. LOUIS — Partek Incorporatedannounced today that its software has been cited in over eight thousand peer-reviewed articles published in scientific journals, including the prestigious PNAS, Cell, and Nature Medicine journals. Topics throughout their twenty-seven-year history range from drug research, human genetics and disease relationships to causes, diagnosis, and treatments. Samples of scientific papers citing the use of Partek […]
New Panel to Provide Support During Onset of Flu Season in the Midst of the COVID-19 Pandemic San Francisco, CA — As the world continues to battle COVID-19, health officials are preparing for the possibility of more co-infections with the onset of the Flu Season. Studies show a high frequency of co-infections in patients with […]
Collaboration will utilize PacBio’s highly accurate HiFi sequencing to solve rare pediatric genetic diseases that have proven intractable in previous studies KANSAS CITY, Mo., and MENLO PARK, Calif. — Children’s Mercy Kansas City, one of the nation’s top pediatric medical systems, and Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of […]
NEW YORK – Geneyx Genomex said Monday that it has acquired Toldot Genetics. Geneyx acquired Toldot from biomedical informatics firm BATM Advanced Communications and several minority shareholders, who in return received a 5 percent equity stake in Geneyx. Additional terms of the deal were not disclosed. Geneyx, an Israel-based developer of genomic analysis and interpretation software, […]
ERS Genomics announces agreement with FASMAC to commercialize CRISPR/Cas9 research reagents in Japan
Food analysis and biotechnology company licenses gene editing technology Dublin, Ireland, and Kanagawa, Japan: ERS Genomics Limited (“ERS”), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced it has signed an agreement with FASMAC Co., Ltd (“FASMAC”) of Japan. Under the terms of the […]
ST. LOUIS & NATICK, Mass. — PierianDx, the leading clinical genomics informatics company, and Pillar Biosciences, a leading next-generation sequencing clinical oncology company, today announced a partnership that enables Pillar Biosciences to sell directly the PierianDx clinical genomic report in combination with its cancer profiling assays. Under the agreement, PierianDx will integrate the Pillar Biosciences […]
Latest Addition to the Mastermind Genomic Search Engine will Further Accelerate Clinical Workflow Genomenon® announced today that the latest release of the Mastermind® Genomic Search Engine includes Copy Number Variation (CNV) search. Since 5-30% of genetic disease is caused by deletion or duplication of genomic material, this new functionality will further accelerate diagnosis and interpretation of results for patients […]
Oxford, UK: The funding comes from existing investors and new investors, including International Holdings Company (IHC) and RPMI Railpen. The funds will support the rapid acceleration of Oxford Nanopore’s commercial and manufacturing operations as well as ongoing innovation in the field of nanopore technology. “We are delighted to welcome our new shareholders,” said Dr Gordon […]
IP Group plc – Portfolio company Oxford Nanopore Technologies announces £84.4m of additional funding
IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property-based businesses, notes that its portfolio company Oxford Nanopore Technologies Ltd (“Oxford Nanopore” or “the Company”) has announced that it has raised an additional £84.4 million of new capital from existing and new investors including International Holdings Company (IHC) and RPMI […]
Partnership Combines Twist’s Leadership in DNA Synthesis and Synthetic Biology with Neogene’s Expertise in Personalized Engineered T Cell Therapies SOUTH SAN FRANCISCO, Calif. & AMSTERDAM & NEW YORK–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Neogene Therapeutics, Inc., a biotechnology […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
